NOVAVAX INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for NOVAVAX INC (NVAX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are NVAX insiders buying or selling?
NOVAVAX INC insiders reported no open-market purchases or sales in the last 12 months. Since February 2018, Trabud has recorded 101 Form 4 filings for NVAX: 12 buys ($584.0K) and 89 sells ($166.3M).
Source: SEC EDGAR Form 4
Key Statistics (February 2018 – Jan 2, 2025)
Total Form 4 filings
101
SEC EDGAR
Insider filers
10
Insider buys (12)
$584.0K
Insider sells (89)
$166.3M
Insider sentiment
Net sellingNet insider flow of $165.8M in net selling since February 2018.
Recent NVAX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Rachel K. King | Director | Sale | 4.2K | $9.02 | $37.4K | SEC ↗ |
| Jan 2, 2025 | James F Young | Director | Sale | 10.0K | $8.22 | $82.2K | SEC ↗ |
| Jun 25, 2024 | James F Young | Director | Sale | 7.5K | $14.09 | $105.7K | SEC ↗ |
| Jun 21, 2024 | James F Young | Director | Sale | 7.5K | $13.72 | $102.9K | SEC ↗ |
| Jun 20, 2024 | Filip Dubovsky | President, R&D | Sale | 13.9K | $14.47 | $201.2K | SEC ↗ |
| May 16, 2024 | Filip Dubovsky | President, R&D | Sale | 47.3K | $13.90 | $657.6K | SEC ↗ |
| Mar 14, 2023 | Gregory M Glenn | President, R&D | Purchase | 6.0K | $7.17 | $43.0K | SEC ↗ |
| Apr 4, 2022 | James F Young | Director | Sale | 12.5K | $73.58 | $919.8K | SEC ↗ |
| Jan 5, 2022 | John A Herrmann III | EVP, Chief Legal Officer | Sale | 5.0K | $140.91 | $704.5K | SEC ↗ |
| Jan 4, 2022 | James F Young | Director | Sale | 3.8K | $144.16 | $540.6K | SEC ↗ |
| Dec 22, 2021 | John A Herrmann III | EVP, Chief Legal Officer | Sale | 5.0K | $230.00 | $1.1M | SEC ↗ |
| Dec 16, 2021 | Gregory M Glenn | President, R&D | Sale | 1.7K | $174.13 | $293.6K | SEC ↗ |
| Dec 9, 2021 | Gregory M Glenn | President, R&D | Sale | 8.3K | $170.14 | $1.4M | SEC ↗ |
| Dec 3, 2021 | John A Herrmann III | EVP, Chief Legal Officer | Sale | 5.0K | $196.19 | $980.9K | SEC ↗ |
| Dec 2, 2021 | Gregory M Glenn | President, R&D | Sale | 8.9K | $203.20 | $1.8M | SEC ↗ |
| Dec 1, 2021 | John A Herrmann III | EVP, Chief Legal Officer | Sale | 5.0K | $228.72 | $1.1M | SEC ↗ |
| Nov 30, 2021 | Gregory M Glenn | President, R&D | Sale | 2.1K | $218.07 | $454.2K | SEC ↗ |
| Nov 24, 2021 | Gregory M Glenn | President, R&D | Sale | 8.3K | $199.50 | $1.6M | SEC ↗ |
| Nov 17, 2021 | Gregory M Glenn | President, R&D | Sale | 9.4K | $169.79 | $1.6M | SEC ↗ |
| Nov 12, 2021 | Gregory M Glenn | President, R&D | Sale | 8.3K | $167.53 | $1.4M | SEC ↗ |
| Nov 5, 2021 | John A Herrmann III | EVP, Chief Legal Officer | Sale | 5.0K | $200.00 | $1.0M | SEC ↗ |
| Nov 4, 2021 | Gregory M Glenn | President, R&D | Sale | 8.3K | $183.82 | $1.5M | SEC ↗ |
| Nov 3, 2021 | John A Herrmann III | EVP, Chief Legal Officer | Sale | 5.0K | $163.08 | $815.4K | SEC ↗ |
| Nov 2, 2021 | Gregory M Glenn | President, R&D | Sale | 680 | $148.34 | $100.9K | SEC ↗ |
| Oct 28, 2021 | Gregory M Glenn | President, R&D | Sale | 10.3K | $132.73 | $1.4M | SEC ↗ |
Showing the 25 most recent of 101 Form 4 filings for NOVAVAX INC.
Most active NVAX insiders
- Gregory M Glenn39 filings
- John A Herrmann III20 filings
- John Trizzino15 filings
- James F Young8 filings
- Stanley C Erck7 filings
Ask anything about NVAX insider activity
Use Trabud's AI agent to query NOVAVAX INC's Form 4 history in plain English — "Show me NVAX CEO purchases this year" or compare it against any other ticker.
Open the AI agentNVAX insider trading FAQ
Are NOVAVAX INC insiders buying or selling?
NOVAVAX INC insiders reported no open-market purchases or sales in the last 12 months. Since February 2018, Trabud has recorded 101 Form 4 filings for NVAX: 12 buys ($584.0K) and 89 sells ($166.3M). Over the full record that is net selling of $165.8M.
How many insiders trade NVAX stock?
10 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for NOVAVAX INC. The most recent filing was accepted on Jan 2, 2025.
Where does Trabud get NVAX insider trading data?
All NVAX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.